Liu Jie, Ke Jun, Lu Yingfei, Zhou Kan, Yu Changjiang, Zhen Jianfan, Jiang Zhuohang, Wu Jinlin, Sun Tucheng
School of Medicine, South China University of Technology, Guangzhou, China.
Department of Cardiac Surgery, Guangdong Cardiovascular Institute, Guangdong Provincial People' s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
J Thorac Dis. 2024 Jun 30;16(6):3732-3739. doi: 10.21037/jtd-24-71. Epub 2024 Jun 18.
Thoracic endovascular aortic repair (TEVAR) is a widely employed clinical procedure for treating various aortic pathologies. However, some patients require subsequent surgical interventions post-TEVAR, particularly due to life-threatening complications such as aortic dissection. This study aimed to evaluate the safety and prognosis associated with additional aortic surgeries following TEVAR.
A retrospective analysis was conducted on 21 patients who underwent aortic surgery after TEVAR at Guangdong Provincial People's Hospital between September 2016 and August 2020. By compiling and reviewing perioperative data, we assessed surgical-related complications and survival rates.
Among the 21 patients, 95.2% were male, with an average age of 53 years. Preoperative comorbidities included hypertension in 15 individuals, abdominal aortic aneurysm in one patient, and coronary heart disease in two patients. The primary complications of TEVAR were stent leakage and retrograde aortic dissection, with the latter being the predominant type in subsequent aortic surgeries. The mean duration of aortic clamping during surgery was 130.0 minutes, with a deep hypothermic circulatory arrest time of 8.5 minutes. Postoperatively, two patients suffered in-hospital mortality, one developed renal dysfunction, four required re-entry into the operating room for further treatment, and the average length of hospital stay was 20 days. Following discharge, 14.3% of patients experienced complications, with central nervous system symptoms being the most prevalent. Kaplan-Meier survival analysis indicated a 5-year survival rate of 85.7%.
Aortic surgical intervention following TEVAR is a safe therapeutic approach that can improve patient prognosis. However, meticulous management of the perioperative period is crucial for reducing the risk of complications and improving survival rates. This study provides valuable insights into aortic surgery post-TEVAR, but large-scale research is needed to validate these findings.
胸主动脉腔内修复术(TEVAR)是治疗各种主动脉病变广泛应用的临床手术。然而,一些患者在TEVAR术后需要后续手术干预,特别是由于诸如主动脉夹层等危及生命的并发症。本研究旨在评估TEVAR术后再次进行主动脉手术的安全性和预后。
对2016年9月至2020年8月在广东省人民医院接受TEVAR术后主动脉手术的21例患者进行回顾性分析。通过收集和回顾围手术期数据,我们评估了手术相关并发症和生存率。
21例患者中,95.2%为男性,平均年龄53岁。术前合并症包括15例高血压、1例腹主动脉瘤和2例冠心病。TEVAR的主要并发症是支架漏血和逆行性主动脉夹层,后者是后续主动脉手术中的主要类型。手术期间主动脉阻断的平均持续时间为130.0分钟,深低温停循环时间为8.5分钟。术后,2例患者发生院内死亡,1例出现肾功能障碍,4例需要再次进入手术室进行进一步治疗,平均住院时间为20天。出院后,14.3%的患者出现并发症,中枢神经系统症状最为常见。Kaplan-Meier生存分析显示5年生存率为85.7%。
TEVAR术后主动脉手术干预是一种安全的治疗方法,可以改善患者预后。然而,围手术期的精心管理对于降低并发症风险和提高生存率至关重要。本研究为TEVAR术后主动脉手术提供了有价值的见解,但需要大规模研究来验证这些发现。